ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,480,141, issued on Nov. 25, was assigned to Alia Therapeutics Srl (Milan).
"Type V Cas proteins and applications thereof" was invented by Antonio Casini (Trento, Italy), Antonio Carusillo (Trento, Italy), Veronica Pinamonti (Trento, Italy), Matteo Ciciani (Schio, Italy) and Maddalena Bosetti (Terre d'Adige, Italy).
According to the abstract* released by the U.S. Patent & Trademark Office: "Type V Cas proteins, for example Type V Cas proteins referred to as ZWGD, ZJHK, ZIKV, ZZFT, YYAN, ZZGY, ZKBG, ZZKD, ZXPB, ZPPX, ZXHQ, ZQKH, ZRGM, ZTAE, ZSQQ, ZSYN, ZRBH, ZWPU, ZZQE, and ZRXE Type V Cas proteins; gRNAs for Type V Cas proteins; systems comprising Type V Cas proteins and gRNAs; nuclei...